The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis. The 14 patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy. The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled. Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-536 (D. Minn. filed Mar. 14, 2005).

Experience Center

Match our Experience to Your Needs

Experience Highlights

$20 million senior-secured revolving credit facility to a domestic and international manufacturer and distributor of lumber and steel products
Represented a commercial finance company as agent and lender in connection with a $20 million senior-secured revolving credit facility provided to a more
Litigated consumer credit and credit rating dispute on behalf of a global leader in information solutions
Representing a global leader in information solutions in numerous individual and class actions arising out of consumer credit and credit rating more
Zero-discharge TMDL challenge for one of the largest U.S. forest products manufacturers
Represented one of the largest U.S. forest products manufacturers with regard to the challenge of zero-discharge TMDL for a river basin. more
Wage and hour litigation for national logistics company
Successfully defended a national logistics company in a lawsuit alleging violations of FLSA, wage and hour laws. more